HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aberrant connexin 43 and 26 expression in cervical dysplasia.

AbstractOBJECTIVE:
To determine whether connexin (Cx) expression is altered in cervical dysplasia.
STUDY DESIGN:
Cx proteins form gap junctions and are expressed in squamous epithelia including ectocervix. We used multispectral imaging to perform a quantitative immunohistochemical survey of Cx43 Cx26 in 37 archival human cervical specimens.
RESULTS:
Cx43 expression was very low in normal cervix (100%), but was increased in low-grade squamous intraepithelial lesions (LSILs) (64%), primarily in a parabasal distribution. High-grade squamous intraepithelial lesions (HSILs) showed weak full-thickness Cx43 staining (53%) or lacked Cx43 (47%). An aberrant increase in Cx43 expression was often (62%) present in histologically normal areas of specimens that elsewhere harbored dysplasia. Cx26 was highly expressed in the basal layer of normal ectocervix (100%). In LSIL, 57% showed a decrease in Cx26 and the rest showed no change relative to the normal pattern. In HSIL, Cx26 was expressed in the full thickness of the epithelium, at a high level in 80% of cases and a low level in the rest.
CONCLUSION:
Cx alteration is moderately consistent in cervical dysplasia, and for Cx43 can precede histologic changes. The resulting changes in Cx signaling may be important in the pathogenesis of cervical intraepithelial neoplasia.
AuthorsIan S Hagemann, Theresa L Pasha, Shelley A Roberts, Sabrina W Yum, Paul J Zhang
JournalAnalytical and quantitative cytology and histology (Anal Quant Cytol Histol) Vol. 34 Issue 1 Pg. 28-40 (Feb 2012) United States
PMID22590817 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Connexin 43
  • Connexins
  • GJB2 protein, human
  • Connexin 26
Topics
  • Connexin 26
  • Connexin 43 (biosynthesis, immunology)
  • Connexins (biosynthesis, immunology)
  • Female
  • Humans
  • Immunohistochemistry
  • Uterine Cervical Dysplasia (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: